Overdose deaths from opioids have plunged from 55,296 in 2024 to 44,564 in 2025 — a massive drop the Trump administration is highlighting as proof its fentanyl crackdown is saving lives.
But experts disagree on whether Trump’s policies deserve the credit — or whether the decline started before he took office.
“The Trump administration deserves credit for recognizing that illicit fentanyl is simultaneously a medical crisis, a transnational organized crime enterprise and a national security threat,” Oxford Treatment Center Medical Director Lucas Trautman told the Daily Caller News Foundation.
“The Trump administration deserves credit for recognizing that illicit fentanyl is simultaneously a medical crisis, a transnational organized crime enterprise and a national security threat.”
Trautman pointed to Trump’s most aggressive moves: designating fentanyl-trafficking cartels as foreign terrorist organizations, signing the HALT Fentanyl Act into law in July 2025 — which permanently classifies fentanyl-related substances as Schedule I drugs — and using new Treasury powers to target financial institutions laundering opioid profits.
Fentanyl-associated deaths also dropped substantially under Trump’s watch, according to Centers for Disease Control data.
But Trautman added a critical caveat.
“However, we must acknowledge that overdose mortality began declining after its 2022 peak and fell sharply in 2024, before President Trump returned to office,” he said. “The administration can reasonably claim that its actions may be helping sustain and deepen the decline, but it cannot scientifically claim sole authorship of it.”
In other words: Trump inherited a trend that was already moving in the right direction — and his policies may be accelerating it, not creating it.
All we needed was a new president.
Drug over dose deaths are DOWN and the southern border is CLOSED.
Countless lives are being saved thanks to @POTUS🇺🇸 pic.twitter.com/CHRP7KI6EW
— The White House (@WhiteHouse) January 29, 2026
Other analysts went further — arguing Trump’s war-on-drugs approach is masking the real factors behind the decline.
“There is no evidence that the Trump administration has made any progress in tackling the overdose crisis,” Cato Institute Senior Fellow Jeffrey Singer told the DCNF. “The recent decline in overdose deaths likely reflects several interacting factors — including the unwinding of pandemic-era disruptions that caused overdose deaths to spike, changes in the illicit drug supply and patterns of drug use, greater naloxone availability, and harm-reduction efforts.”
Singer pointed to collapsing drug use among Generation Z — who are drinking, vaping, and using drugs at record low levels — as evidence the decline is cultural, not enforcement-driven.
“The evidence does not support claims that intensified drug-war enforcement deserves substantial credit for the decline, and it remains uncertain whether the decline will continue,” Singer said.
He also criticized Trump for slashing federal funding for harm-reduction programs — needle exchanges, overdose prevention centers, expanded methadone access — that have decades-long track records of reducing deaths in other countries.
“Unfortunately, the administration is turning back the clock by reversing course on earlier efforts to encourage clinicians and private organizations to adopt proven harm reduction techniques,” Singer added. “These strategies, which the current administration appears to be abandoning, might have largely contributed to the post-pandemic decline in overdose deaths.”
The Trump administration recently cut federal funding for needle-exchange programs and drug-testing strips, according to Politico. Some Republican-controlled states have since bolstered their own funding to fill the gap.
Biden’s failure to secure the border allowed fentanyl to pour into our country, killing innocent Americans.
The HALT Fentanyl Act will protect the American people by keeping dangerous drugs out of our communities.
.@POTUS and Congressional Republicans are saving lives. https://t.co/Rl2fUUNBRl
— Speaker Mike Johnson (@SpeakerJohnson) July 16, 2025
Opioid-involved overdose deaths surged from 49,860 in 2019 to a peak of 81,806 in 2022, then began falling to 79,358 in 2023, according to the National Institute on Drug Abuse.
The latest CDC data shows the trend accelerating — dropping to 44,564 in 2025.
In January, Trump issued an executive order launching the “Great American Recovery Initiative” to coordinate government, healthcare, faith communities, and the private sector in fighting addiction.
The White House’s Office of National Drug Control Policy published a statement of “Drug Policy Priorities” in April 2025, laying out first-year steps to “address the scourge of illicit drug use that continues plaguing our nation.”
Trump took similar action during his first term, unveiling $1.8 billion in new grants in September 2019 to help states combat the opioid crisis.
Trautman said the government “should measure success by more than seizures or arrests.”
“The U.S. is finally moving in the right direction, and the mortality decline is real, as I am witnessing as an addictionologist in Mississippi and Tennessee,” he said. “But declaring victory prematurely would be dangerous. We will save the most lives when national security pressure on the supply chain is paired with immediate, low-barrier access to evidence-based treatment, buprenorphine and methadone, at every point where patients are most vulnerable.”
